| 摘要 |
The present invention generally relates to the use of ondansetron, its salts and base, as an active principle in the manufacture of pharmaceutical compositions, more particularly dermatological compositions, intended for a curative and/or prophylactic antiinflammatory treatment, by the topical route. More specifically, the present invention provides the use of Ondansetron, its salt and base to topically treat rosacea, an inflammatory skin disorder. |
